GLP-1 reduced ischemic damage and decreased myocardial infarct size in experimental myocardial infarction in mice11, 12, and recent data indicated that GLP-1 administration improved endothelial function in diabetic patients. The gene discussed is GCG; the disease is myocardial infarction.